Clinical Trial Update: Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents [Phase 3]

View source ↗

Summary

Phase III trial evaluating an autologous dermo-epidermal skin substitute for burns in adults and adolescents is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• Autologous dermo-epidermal skin substitute

Snippet

Sponsor: CUTISS AG | Conditions: Burns | Phase 3 | Status: RECRUITING